WebAug 20, 2024 · For enquiries, please contact: Biofidelity Dr Barnaby Balmforth, CEO T: +44 1223 358652 E: [email protected] Mo PR Advisory Mo Noonan/ Jonathan Birt Tel: +44 (0) 7876 444977 / 07860 361746 WebSep 8, 2024 · Biofidelity, a revolutionary genomic technology company dedicated to unleashing the potential of genomics to transform human health and the world we live in, …
Did you know?
WebJul 28, 2024 · CAMBRIDGE, United Kingdom., July 28, 2024 (GLOBE NEWSWIRE) -- Biofidelity Ltd, the cancer diagnostics company, today announces the opening of its US … WebApr 12, 2024 · Biofidelity. @biofidelity_dx. Five year survival rates for patients with non-small cell lung cancer have “increased dramatically,” says Mayo Clinic pharmacist Scott …
WebSep 8, 2024 · Biofidelity, a revolutionary genomic technology company dedicated to unleashing the potential of genomics to transform human health and the world we live in, announced today the issuance of ... WebMar 23, 2024 · Biofidelity Dr Barnaby Balmforth, CEO T: +44 1223 358652 E: [email protected]: Mo PR Advisory Mo Noonan/ Jonathan Birt Tel: +44 (0) 7876 444977 / (0) 7860 361746
WebSep 8, 2024 · The ASPYRE technology is protected by 22 granted patents, including two US patents, US10,961,569 and US11,332,780, Chinese patent CN112424379, and patents in key European countries, including the ... WebOct 18, 2024 · News provided by. Biofidelity Oct 18, 2024, 08:15 ET. Share this article. Share this article. Current sequencing methods miss gene fusions for many non-small cell lung cancer patients denying them ...
WebOct 18, 2024 · Biofidelity raises $12m in Series A financing to accelerate launch of disruptive cancer diagnostic technology Biofidelity. Aug 20. 2024. Supported by BlueYard Capital, Longwall Ventures and Agilent …
WebBiofidelity News & Media Matt Franklin, MBA, appointed as Biofidelity Non-Executive Director CAMBRIDGE, England and RESEARCH TRIANGLE PARK, N.C., Nov. 17, 2024 /PRNewswire/ -- Biofidelity, a revolutionary genomic technology company, has expanded its Board of Directors to include Matt Franklin, MBA, who will join as a Non-Executive … birthdays on nov 5WebJul 15, 2024 · New Scientific Advisory Board combines decades of industry, academic and patient advocacy oncology leadership to help guide development & launch of Biofidelity's breakthrough ASPYRE diagnostic ... birthdays on nov 14WebApr 10, 2024 · De 2024 a 2024, 895 instituições de pesquisas no Brasil cadastradas no Conselho Nacional de Controle de Experimentação Animal, o Concea, tiveram a autorização para utilizar mais de 16 ... dan the progressive liberalWebLGC Clinical Diagnostics blog encompasses blog articles from all of our product brands: Maine Standards, SeraCare, and The Native Antigen Company. All LGC CDx Articles. Antigens & Antibodies. Biochemistry (CalVer & QC) Molecular. NGS (Next Generation Sequencing) Serology. dan the rail fan manWebBiofidelity developed a revolutionary molecular diagnostic assay that enables the rapid detection of target DNA sequences. Biofidelity’s mission is to improve and extend … dan the real estate man.bizWebJul 28, 2024 · Cambridge, UK, 28 July 2024 – Biofidelity Ltd, the cancer diagnostics company, today announces the opening of its US headquarters in Research Triangle Park, North Carolina, expanding its presence in the key US market ahead of its first product launch later this year. The location will house a state-of-the-art clinical cancer diagnostic … birthdays on march 8WebAug 31, 2024 · SOPHIA ANTIPOLIS, France – August 31, 2024 Biofidelity recently announced that it has raised $12 million, completing its Series A financing.The company disclosed that the series A investors are BlueYard Capital, Longwall Ventures and Agilent Technologies. Biofidelity is, above all, focused on developing non-small cell lung cancer … dan the puppet man